Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | 242,000 | 299,000 | 1,067,000 | 587,000 | 1,804,000 |
| Other Operating Activity | 2,891,000 | 2,099,000 | 1,863,000 | 661,000 | 1,428,000 |
| Operating Cash Flow | $3,133,000 | $2,398,000 | $2,930,000 | $1,248,000 | $3,232,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122,000 | -107,000 | -230,000 | -253,000 | -219,000 |
| Net Acquisitions | -426,000 | -189,000 | -342,000 | -288,000 | -242,000 |
| Purchase Of Investment | 0 | 190,000 | -321,000 | -24,000 | -4,000 |
| Sale Of Investment | 19,000 | 0 | -2,000 | -9,000 | 53,000 |
| Purchase Sale Intangibles | -959,000 | -177,000 | -864,000 | -233,000 | 241,000 |
| Other Investing Activity | 506,000 | 39,000 | 16,000 | 64,000 | 388,000 |
| Investing Cash Flow | $-1,246,000 | $-249,000 | $-1,743,000 | $-800,000 | $-168,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 97,000 | -304,000 | 62,000 | 15,000 | 301,000 |
| Debt Issued | 3,826,000 | 0 | 0 | N/A | N/A |
| Debt Repayment | -2,004,000 | -10,000 | -4,000 | -1,253,000 | -4,000 |
| Common Stock Issued | 4,000 | 18,000 | 3,000 | 3,000 | 5,000 |
| Dividend Paid | -3,047,000 | 0 | -1,393,000 | 0 | -2,971,000 |
| Other Financing Activity | -907,000 | -62,000 | -98,000 | -60,000 | -1,071,000 |
| Financing Cash Flow | $-2,031,000 | $-358,000 | $-1,430,000 | $-1,295,000 | $-3,740,000 |
| Exchange Rate Effect | -11,000 | 6,000 | -51,000 | -26,000 | -9,000 |
| Beginning Cash Position | 5,983,000 | 4,186,000 | 4,480,000 | 5,353,000 | 6,038,000 |
| End Cash Position | 5,828,000 | 5,983,000 | 4,186,000 | 4,480,000 | 5,353,000 |
| Net Cash Flow | $-144,000 | $1,791,000 | $-243,000 | $-847,000 | $-676,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,133,000 | 2,398,000 | 2,930,000 | 1,248,000 | 3,232,000 |
| Capital Expenditure | -1,470,000 | -554,000 | -1,111,000 | -543,000 | -363,000 |
| Free Cash Flow | 1,663,000 | 1,844,000 | 1,819,000 | 705,000 | 2,869,000 |